Movicolon Junior Naturel

Macrogol 3350, the active ingredient in Movicolon Junior Naturel, is an osmotic laxative presented as an oral powder for oral use. It helps soften stool and relieve constipation in children.

GNH USA supplies Movicolon Junior Naturel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Movicolon Junior Naturel is used as an osmotic laxative to manage constipation and related conditions in the pediatric population.

- Functional constipation in children: provides gentle stool softening and promotes regular bowel movements. - Encopresis associated with constipation: helps relieve fecal retention and improve continence. - Bowel preparation for pediatric diagnostic procedures: facilitates intestinal cleansing before colonoscopy or imaging.

Common Side Effects: - Abdominal bloating: mild distension of the abdomen. - Flatulence: increased intestinal gas. - Nausea: occasional feeling of queasiness. - Mild abdominal cramps: transient discomfort. - Diarrhea: loose stools if excess fluid is drawn. - Electrolyte imbalance: mild changes in sodium or potassium levels.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss requiring medical attention. - Severe electrolyte disturbances: significant hyponatremia or hyperkalemia. - Allergic reactions: rash, itching, or swelling. - Severe abdominal pain: persistent or worsening pain. - Rectal bleeding: unusual bleeding from the rectum.

Before using Movicolon Junior Naturel, consider the following precautions. - Dose adjustment: in patients with renal impairment, monitor electrolyte status closely. - Electrolyte monitoring: due to sodium and potassium content, assess serum levels regularly. - Fluid intake: ensure adequate hydration to support the osmotic action. - Age restriction: intended for pediatric use as directed by a healthcare professional. - Store at ambient temperature: keep in the original pack, protect from moisture.

Movicolon Junior Naturel may interact with other medications and substances.

Major Interactions (Avoid): - Concurrent use with other osmotic laxatives: risk of severe electrolyte imbalance. - High‑dose potassium supplements: may cause hyperkalemia. - Sodium‑restricted diets: may affect sodium load.

Moderate Interactions (Monitor Closely): - Antacids containing sodium bicarbonate: additive sodium load. - ACE inhibitors: monitor potassium levels for potential hyperkalaemia.